Oncologist-approved cancer information from the American Society of Clinical Oncology

Liver Cancer

News and highlights from ASCO Annual Meetings.


Category :
Year :
 
 
New Drug Helps Patients With Advanced Liver Cancer Live Longer
June 4, 2007

A new study shows that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44% longer than patients who did not receive this drug. Sorafenib is a pill that is taken by mouth. It is approved in the United States for treating a type of advanced kidney cancer and is being studied for treating other cancers.


<<Previous | Page 1 of 1 | Next>>